9I4V
Crystal structure of the SARS-CoV-2 helicase NSP13
Summary for 9I4V
Entry DOI | 10.2210/pdb9i4v/pdb |
Related | 9I1S |
Descriptor | SARS-CoV-2 helicase NSP13, ZINC ION, PHOSPHATE ION, ... (5 entities in total) |
Functional Keywords | nsp13, helicase, sars-cov-2, hydrolase |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 2 |
Total formula weight | 135488.47 |
Authors | |
Primary citation | Kloskowski, P.,Neumann, P.,Kumar, P.,Berndt, A.,Dobbelstein, M.,Ficner, R. Myricetin-bound crystal structure of the SARS-CoV-2 helicase NSP13 facilitates the discovery of novel natural inhibitors. Acta Crystallogr D Struct Biol, 81:310-326, 2025 Cited by PubMed Abstract: The SARS-CoV-2 helicase NSP13 is a highly conserved and essential component of the viral replication machinery, making it a promising target for antiviral drug development. Here, we present the 2 Å resolution crystal structure of NSP13 bound to the natural flavonoid myricetin, revealing a conserved allosteric binding site. Guided by these structural findings, a virtual screening campaign identified the caffeic acid derivatives rosmarinic acid and chlorogenic acid as potential novel natural inhibitors, which were experimentally validated to inhibit RNA-unwinding activity. This study provides structural insights that could support ongoing drug-discovery efforts targeting NSP13 in SARS-CoV-2 and other coronaviruses with pandemic potential. PubMed: 40421686DOI: 10.1107/S2059798325004498 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.33 Å) |
Structure validation
Download full validation report
